GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » Cyclically Adjusted Revenue per Share

Episurf Medical AB (OSTO:EPIS B) Cyclically Adjusted Revenue per Share : kr0.06 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Episurf Medical AB's adjusted revenue per share for the three months ended in Mar. 2025 was kr0.006. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr0.06 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Episurf Medical AB was 6.30% per year. The lowest was -10.60% per year. And the median was 6.30% per year.

As of today (2025-07-05), Episurf Medical AB's current stock price is kr0.0541. Episurf Medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr0.06. Episurf Medical AB's Cyclically Adjusted PS Ratio of today is 0.90.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Episurf Medical AB was 71.51. The lowest was 1.50. And the median was 20.50.


Episurf Medical AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Episurf Medical AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB Cyclically Adjusted Revenue per Share Chart

Episurf Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.05 0.06 0.06

Episurf Medical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.06 0.06 0.06

Competitive Comparison of Episurf Medical AB's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Episurf Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Episurf Medical AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Episurf Medical AB's Cyclically Adjusted PS Ratio falls into.


;
;

Episurf Medical AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Episurf Medical AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.006/132.8245*132.8245
=0.006

Current CPI (Mar. 2025) = 132.8245.

Episurf Medical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.015 99.995 0.020
201509 0.006 100.228 0.008
201512 0.011 100.276 0.015
201603 0.015 100.751 0.020
201606 0.018 101.019 0.024
201609 0.016 101.138 0.021
201612 0.032 102.022 0.042
201703 0.015 102.022 0.020
201706 0.012 102.752 0.016
201709 0.010 103.279 0.013
201712 0.018 103.793 0.023
201803 0.022 103.962 0.028
201806 0.017 104.875 0.022
201809 0.025 105.679 0.031
201812 0.027 105.912 0.034
201903 0.026 105.886 0.033
201906 0.019 106.742 0.024
201909 0.009 107.214 0.011
201912 0.011 107.766 0.014
202003 0.012 106.563 0.015
202006 0.003 107.498 0.004
202009 0.006 107.635 0.007
202012 0.006 108.296 0.007
202103 0.006 108.360 0.007
202106 0.007 108.928 0.009
202109 0.005 110.338 0.006
202112 0.004 112.486 0.005
202203 0.005 114.825 0.006
202206 0.005 118.384 0.006
202209 0.004 122.296 0.004
202212 0.005 126.365 0.005
202303 0.007 127.042 0.007
202306 0.007 129.407 0.007
202309 0.008 130.224 0.008
202312 0.010 131.912 0.010
202403 0.010 132.205 0.010
202406 0.009 132.716 0.009
202409 0.005 132.304 0.005
202412 0.005 132.987 0.005
202503 0.006 132.825 0.006

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Episurf Medical AB  (OSTO:EPIS B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Episurf Medical AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0541/0.06
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Episurf Medical AB was 71.51. The lowest was 1.50. And the median was 20.50.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Episurf Medical AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Episurf Medical AB Business Description

Traded in Other Exchanges
Address
Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.

Episurf Medical AB Headlines

No Headlines